Nan Fung Trinity’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Nan Fung Trinity's XENE Position: Q3 2026 in Review
Nan Fung Trinity held its Xenon Pharmaceuticals (XENE) position steady in Q3 2026 at 247,765 shares worth $9.21M. The position accounts for 0.88% of the portfolio, ranked #42.
Nan Fung Trinity first reported a position in XENE in Q2 2025 and has held it in 6 quarters since. The position peaked at $15M in Q2 2026. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Nan Fung Trinity held 247,765 shares of Xenon Pharmaceuticals worth $9.21M as of Q3 2026.
- Nan Fung Trinity left its Xenon Pharmaceuticals share count unchanged in Q3 2026.
- Xenon Pharmaceuticals made up 0.88% of Nan Fung Trinity's portfolio in Q3 2026, its #42 holding.
- Nan Fung Trinity first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Nan Fung Trinity's Xenon Pharmaceuticals position peaked at $15M in Q2 2026.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Nan Fung Trinity's 13F filing for Q3 2026, filed 6 Nov 2026.